Amundi Has $1.35 Billion Stock Position in Intuitive Surgical, Inc. $ISRG

Amundi reduced its stake in Intuitive Surgical by 24.7% in Q2, now holding 2,488,028 shares valued at $1.35 billion. Other institutional investors like Norges Bank and Vanguard Group have also adjusted their positions. Analysts have varied ratings on Intuitive Surgical, with a consensus price target of $607.17. Insider transactions include significant stock sales by executives. Intuitive Surgical's stock opened at $568.63, with a market cap of $203.84 billion.

Amundi lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 24.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,488,028 shares of the medical equipment provider's stock after selling 815,166 shares during the quarter. Amundi owned approximately 0.69% of Intuitive Surgical worth $1,345,028,000 at the end of the most recent quarter.

Get Intuitive Surgical alerts:

$134M in Insider Moves: What It Might Mean for KMI, ISRG and QS

Several other institutional investors have also made changes to their positions in ISRG. Norges Bank bought a new position in Intuitive Surgical during the second quarter valued at approximately $2,569,260,000. Nuveen LLC acquired a new position in shares of Intuitive Surgical during the 1st quarter worth $1,715,899,000. Vanguard Group Inc. increased its stake in shares of Intuitive Surgical by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider's stock worth $18,115,025,000 after purchasing an additional 670,302 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Intuitive Surgical by 20.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider's stock valued at $1,680,922,000 after purchasing an additional 566,979 shares in the last quarter. Finally, Jennison Associates LLC lifted its stake in shares of Intuitive Surgical by 20.4% in the 2nd quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider's stock valued at $1,696,738,000 after purchasing an additional 528,359 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Jefferies Financial Group increased their target price on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a "hold" rating in a research report on Wednesday, October 22nd. Piper Sandler increased their price objective on Intuitive Surgical from $595.00 to $610.00 and gave the company an "overweight" rating in a report on Wednesday, October 22nd. Evercore ISI raised their price objective on Intuitive Surgical from $450.00 to $540.00 in a research note on Wednesday, October 22nd. Royal Bank Of Canada set a $625.00 target price on Intuitive Surgical and gave the stock an "outperform" rating in a research report on Wednesday, October 22nd. Finally, Rothschild & Co Redburn increased their price target on Intuitive Surgical from $610.00 to $615.00 and gave the company a "buy" rating in a report on Thursday, October 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus price target of $607.17.

Top 3 Stocks Powering Through Trump’s Tariff Policies

Read Our Latest Research Report on Intuitive Surgical

Insider Buying and Selling

In related news, insider Gary S. Guthart sold 28,800 shares of the stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $547.56, for a total value of $15,769,728.00. Following the completion of the transaction, the insider owned 27,027 shares of the company's stock, valued at $14,798,904.12. This represents a 51.59% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Myriam Curet sold 7,562 shares of the business's stock in a transaction on Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total value of $4,147,227.66. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $193,595.79. This represents a 95.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 108,939 shares of company stock worth $60,757,995. Insiders own 0.70% of the company's stock.

Intuitive Surgical Price Performance

Why Intuitive Surgical Is a No-Brainer for Long-Term Investors

NASDAQ ISRG opened at $568.63 on Friday. The firm has a market capitalization of $203.84 billion, a price-to-earnings ratio of 75.22, a P/E/G ratio of 5.24 and a beta of 1.68. The company's fifty day moving average is $515.92 and its two-hundred day moving average is $505.59. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts' consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same quarter in the prior year, the business earned $1.84 earnings per share. The firm's revenue for the quarter was up 22.9% on a year-over-year basis. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here